Behcet’s disease is an inflammatory condition that affects blood vessels throughout the body. People with Behcet’s disease often have mouth sores, genital sores, eye inflammation, and skin bumps, and some feel joint pain or headaches. Symptoms can flare and then settle, and the condition tends to be long term. It most often starts in early adulthood and is more common in people from the Middle East, East Asia, and the Mediterranean, but anyone can develop it. Treatment focuses on controlling flares with anti-inflammatory medicines and immune-suppressing drugs, and most people with Behcet’s disease live a normal lifespan, though severe eye or organ involvement needs prompt care.
Overview
Behcet's diseaseSymptoms
Behcet's disease often flares with painful mouth sores, genital ulcers, red painful eyes or blurred vision, acne-like or tender skin bumps, and joint pain. Early symptoms of Behcet's disease can include fatigue and recurring mouth ulcers.
Outlook and prognosis
Most people with Behcet’s disease have flare‑ups that come and go, with quiet periods in between. With tailored treatment and routine follow‑up, many keep mouth and genital sores, eye inflammation, and skin symptoms under good control and protect vision. Regular care helps prevent long‑term complications.
Causes and risk factors
Behcet's disease arises from an overactive immune response in genetically susceptible people, often linked to HLA‑B51. Possible triggers include infections. Risk is higher in people from the Middle East or East Asia, ages 20–40; men may have more severe disease.
Genetic influences
Genetics play a meaningful role in Behcet’s disease, but they aren’t the whole story. Variants like HLA-B51 raise risk, especially in certain populations, yet many carriers never develop symptoms. Environment, infections, and immune triggers interact with these genetic factors.
Diagnosis
Diagnosis of Behcet's disease is clinical: recurrent mouth ulcers plus genital sores, eye inflammation, or skin findings over time. No single test confirms it; a pathergy skin test may support. Blood tests, eye exams, and imaging help rule out look-alikes.
Treatment and drugs
Treatment for Behcet’s disease focuses on calming flares, protecting vision, and preventing long-term damage. Plans often combine steroid eye drops or short courses of oral steroids with immune-calming medicines like colchicine, azathioprine, or biologics. Regular check-ins help adjust dosing and manage side effects.
Symptoms
With Behcet's disease, symptoms tend to come and go in flares, affecting different parts of the body. Early symptoms of Behcet's disease often include painful mouth sores and tender skin bumps, which can make eating or walking uncomfortable. Symptoms vary from person to person and can change over time. Eye pain or blurry vision, joint aches, and fatigue are also common, and some people develop problems in the gut, nerves, or blood vessels.
Painful canker-like ulcers inside the lips, cheeks, or on the tongue are common. They tend to heal in 1–3 weeks but often come back in cycles. They’re the most common flare in Behcet's disease.
Tender ulcers can appear on the vulva, scrotum, or groin. They may leave small scars after healing. Sitting, sex, or going to the toilet can become uncomfortable during a flare.
Red, sore lumps—often on the shins—can feel like deep bruises. Acne-like bumps or small pus-filled spots may also show up on the face, chest, or back. Shaving or pressure from clothing can make sore areas more noticeable.
Eye pain, redness, light sensitivity, or blurry vision can come on suddenly. Eye inflammation is a major concern in Behcet's disease and may clear, then recur. If these changes affect daily life, consider speaking with a healthcare professional.
How people usually first notice Behcet's disease?
Many people first notice Behçet’s disease when mouth sores keep coming back—often painful, shallow ulcers that look like canker sores but recur in clusters and heal, then return. Some then develop genital sores, eye redness with pain or blurry vision, or tender red bumps on the legs, and may link these flare-and-calm patterns only after several episodes. Doctors are often alerted by this combination of recurring ulcers and inflammation, so keeping notes or photos of flares can help show the first signs of Behçet’s disease and how Behçet’s is first noticed.
Types of Behcet's disease
Behcet's disease can look different from one person to the next, and doctors often describe patterns based on which areas of the body are most affected. People may notice different sets of symptoms depending on their situation. Some have mostly mouth and skin flares, while others deal more with eye inflammation, joint pain, or blood vessel problems. When people search for types of Behcet's disease, they’re usually asking about these clinical patterns rather than completely separate diseases.
Mucocutaneous-predominant
Mouth and genital ulcers, plus acne-like or tender red skin bumps, flare and settle over time. Pain and fatigue often track with these flares. Eye, joint, or organ involvement may be mild or absent.
Ocular-predominant
Eye inflammation causes redness, light sensitivity, blurry vision, or floaters. Without treatment, repeated flares can threaten sight. Early symptoms of Behcet's disease in the eyes may be subtle at first.
Articular-predominant
Achy, swollen joints—often knees, ankles, wrists, or elbows—come and go. Stiffness can be worse in the morning or after rest. Joint changes are usually inflammatory but not the same as permanent joint damage in arthritis.
Vascular-predominant
Vein inflammation can lead to tender cords or swollen limbs, and artery involvement can cause pain or more serious complications. Clots may form in unusual places, such as large veins. Care teams watch closely because blood vessel flares need prompt treatment.
Neurologic-predominant
Headaches, balance problems, weakness, or behavior and mood changes can occur when the brain or its coverings are inflamed. Symptoms may build over days to weeks. Imaging and spinal fluid tests often guide diagnosis and treatment.
Gastrointestinal-predominant
Belly pain, diarrhea, and bleeding can appear when the gut is inflamed, often in the lower small intestine or colon. Flares can mimic other bowel conditions. Endoscopy and imaging help tell them apart and guide care.
What genetics can tell you about symptoms
Some people with certain HLA-B51 gene versions are more likely to have Behçet’s symptoms like painful mouth or genital ulcers, eye inflammation, and skin bumps. These gene changes don’t cause the disease by themselves, but they tilt the immune system toward overreacting.
Causes and risk factors
The exact cause is unknown, but the immune system misfires and inflames blood vessels. Genetics can raise susceptibility, and infections or other triggers can set off inflammation. It’s rarely just one factor, and the mix matters. Risk factors for Behcet's disease include ancestry from the Middle East, Mediterranean, or East Asia, age 20 to 40, and being male in some regions. Some people notice flares after stress or illness, and many with these risks never develop the disease.
Environmental and biological risk factors
Behcet’s disease is an inflammatory condition that can flare and quiet over time, affecting blood vessels in many parts of the body. While people often look up early symptoms of Behcet’s disease, it also helps to understand what in the body and environment can raise risk. Doctors often group risks into internal (biological) and external (environmental). Below are well-recognized environmental and biological risks linked with Behcet’s disease.
Rates are higher in countries along the Mediterranean, Middle East, and East Asia. Living in or spending long periods in these regions is linked with greater risk of Behcet’s disease. Moving away does not immediately remove that background risk.
First signs most often appear between ages 20 and 40 years. Behcet’s disease can start at any age, but outside this range it is less common.
In some higher-prevalence regions, men develop Behcet’s disease more often and may have more severe features. In Western Europe and the United States, women and men are affected at more similar rates.
Immune activation after common bacterial or viral infections can precede the onset or a flare of Behcet’s disease. Throat or mouth infections are frequent examples that can stir up the immune system.
Genetic risk factors
Genetics play a meaningful role in who develops Behcet's disease, but no single gene explains it. Research has identified several genetic risk factors for Behcet's disease, especially certain immune system genes that guide how the body recognizes its own tissues. Carrying a genetic change doesn’t guarantee the condition will appear. Family background and ancestry can shape risk because some genetic patterns are more common in certain populations.
HLA-B51 allele: This immune gene is the strongest known genetic association with Behcet's disease. Having HLA‑B51 raises risk, but many carriers never develop symptoms.
ERAP1 variants: Changes in this gene can alter how proteins are trimmed and shown to the immune system. The added risk is most evident in people who also carry HLA‑B51.
IL10 gene changes: Variants linked to lower IL‑10 levels can make it harder to calm inflammation. These changes modestly increase susceptibility to Behcet's disease.
IL23R/IL12RB2 region: Variants in this pathway can tilt immune responses toward a more inflammatory state. The effect size is moderate compared with HLA‑B51.
STAT4 variants: This immune signaling gene has been associated with higher risk in several studies. The increase in risk is small but consistent.
CCR1–CCR3 region: Changes near these genes may affect how white blood cells move into tissues. Certain variants are linked with slightly higher risk.
Family history: Having a close relative with Behcet's disease raises your personal risk. Even then, the condition remains uncommon in most families.
Ancestry patterns: People with roots in regions along the historical Silk Road have higher rates, reflecting shared genetic backgrounds. This helps explain why Behcet's disease is more frequent in parts of Türkiye, the Middle East, North Africa, and East Asia.
Other HLA types: Beyond HLA‑B51, some HLA variants modestly change risk depending on ancestry. Their impact is smaller and less consistent across populations.
Lifestyle risk factors
Behcet's disease can flare or become more complicated based on daily habits and behaviors. The lifestyle risk factors for Behcet's disease include choices that influence inflammation, vascular risk, and mucosal irritation. Adjusting these factors can help reduce flare frequency and protect eyes, blood vessels, skin, and joints.
Tobacco promotes vascular inflammation and raises blood clot risk, a serious Behcet’s complication. Smokers with Behcet’s tend to have more severe oral and eye involvement.
Frequent intake of refined carbs and ultra-processed foods can amplify systemic inflammation. This may increase oral ulcer frequency and worsen fatigue in Behcet’s.
Alcohol can irritate mouth and genital mucosa, provoking painful ulcers. It may also disrupt sleep and interfere with tolerance of Behcet’s medications, increasing flare risk.
Prolonged inactivity worsens stiffness, fatigue, and deconditioning in Behcet’s. Regular, gentle activity during stable periods can lower clot risk and improve function.
Risk prevention
You can’t fully prevent Behcet’s disease, but you can lower the chance of flares and protect long-term health. Prevention works best when combined with regular check-ups. Most steps focus on reducing triggers, catching problems early, and avoiding complications from inflammation or treatment. Small, steady habits often make a real difference day to day.
See your care team on a schedule, even when you feel well. Regular visits help catch early symptoms of Behcet’s disease and adjust treatment before a flare gains momentum.
Take medicines exactly as prescribed and don’t stop suddenly without medical advice. Consistent use helps keep inflammation quiet and prevents rebound flares.
Brush gently, floss, and use an alcohol-free mouth rinse to lower mouth irritation. Regular dental cleanings can reduce ulcers in people with Behcet’s.
Keep vaccines up to date and practice hand hygiene to lower infection risks that may trigger flares. If you use immune-suppressing treatment, ask which vaccines are safe and which to avoid.
Transmission
Behcet's disease is not contagious. You cannot catch it from someone, and it does not spread through coughing, kissing, sex, blood, or breastfeeding.
The condition stems from an overactive immune response in people with certain inherited risk factors; relatives may have a slightly higher chance, but there is no simple pattern of inheritance and most children of someone with Behcet's disease never develop it. Researchers think infections or other environmental triggers can spark flares in susceptible people, but this is not how Behcet's disease is transmitted from person to person.
When to test your genes
Behçet’s disease is not inherited in a simple way, so routine genetic testing isn’t usually helpful. Consider HLA-B51 testing only if symptoms strongly suggest Behçet’s but diagnosis is unclear, or within research-guided care. Prioritize specialist evaluation; clinical features guide diagnosis and treatment more than genes.
Diagnosis
Behcet’s disease is usually identified by a pattern of symptoms that flare and settle, then confirmed with focused exams and tests. Because there’s no single “yes/no” test, doctors look at how features cluster together over time. Some diagnoses are clear after a single visit, while others take more time. The diagnosis of Behcet’s disease often becomes clearer as your care team tracks symptoms across several months and rules out other causes.
Repeated mouth ulcers plus genital sores, eye inflammation, or specific skin rashes raise suspicion. Doctors look for how often ulcers recur and whether episodes affect more than one body system.
The exam looks for active mouth or genital ulcers, tender skin bumps, and joint swelling. Your provider also checks for signs of blood vessel or nerve involvement.
A slit-lamp exam can detect eye inflammation, including uveitis, even if vision seems fine. Early eye findings help guide urgent treatment to protect sight.
A tiny skin prick is observed for an exaggerated bump or pustule within 24–48 hours. A positive reaction supports Behcet’s disease but is not required for diagnosis.
Stages of Behcet's disease
Behcet's disease does not have defined progression stages. Symptoms tend to flare up and settle down over time, and the pattern can differ a lot from one person to another, so it isn’t tracked as a steady early–late decline. Doctors usually start with a conversation about your symptom history—including early symptoms of Behcet's disease like repeated mouth sores—and then look for a combination of features such as genital sores, eye inflammation, skin changes, or joint pain. Eye checks, targeted exams, and sometimes simple office tests or blood work help rule out other causes and guide follow-up with specialists such as rheumatology or eye doctors.
Outlook and prognosis
Many people ask, “What does this mean for my future?”, and the short answer is that most people with Behcet’s disease can live a long life with the right care. Flare-ups tend to come and go, with quiet stretches in between. Early symptoms of Behcet’s disease—like mouth sores, eye irritation, or skin bumps—may be mild at first and then intensify during flares, but treatment usually shortens flares and reduces their frequency. In medical terms, the long-term outlook is often shaped by both genetics and lifestyle.
Over years, inflammation can involve the eyes, brain, blood vessels, or gut, which is why regular follow-up matters. Severe eye inflammation is a key driver of long-term problems; without treatment it can threaten vision, but today’s therapies have lowered that risk considerably. Blood vessel complications, such as clots or bulging arteries, are less common but can be serious; when these occur, doctors act quickly to prevent lasting harm. The outlook is not the same for everyone, but most people with Behcet’s disease do not face shortened life expectancy, especially when inflammation is controlled early.
Looking at the long-term picture can be helpful. Many people find that symptoms become less intense or less frequent after the first several years, though some continue to have periodic flares. Mortality is uncommon and usually linked to major vessel, brain, or bowel involvement; close monitoring and prompt treatment reduce those risks. Talk with your doctor about what your personal outlook might look like, including how your past flares, eye findings, and any vessel issues shape the plan for the years ahead.
Long-term effects
Behcet's disease often follows a relapsing-remitting course, with flares that settle and return over time. While early symptoms of Behcet's disease often include mouth ulcers, the long-term picture depends on which organs are involved and how frequently flares occur. Long-term effects vary widely, and many people have long stretches with few or no symptoms. Lasting changes can include scarring, vision effects, or blood vessel problems, but severity differs from person to person.
Repeated sores can leave tender areas, scarring, and changes in taste or appetite. Eating, brushing teeth, and speaking may stay uncomfortable during or after flares.
Recurring ulcers may scar and cause long-term sensitivity or pain. Intimacy and urination can be affected during flares and sometimes in between.
Uveitis and other eye flares can lead to blurred vision, light sensitivity, and in some cases permanent vision loss. Regular flares raise the risk of lasting damage in Behcet's disease.
Acne-like bumps or red, painful nodules can leave marks or discoloration over time. Some may notice scarring where lesions recur.
How is it to live with Behcet's disease?
Living with Behçet’s disease can feel unpredictable, with periods of calm interrupted by flares of mouth or genital ulcers, skin bumps, eye pain, or joint aches that make everyday plans harder to keep. Fatigue can be heavy, and some may need to pace activities, plan around medical appointments, and keep emergency eye care in mind if vision changes. Work, school, and relationships can be affected when symptoms flare, and people around you may need clear cues about when you need flexibility, help with errands, or simply patience. Many find that learning personal triggers, sticking with treatment, and building a supportive care team and social circle makes life steadier and more manageable.
Treatment and drugs
Behcet’s disease treatment focuses on calming inflammation, easing symptoms during flares, and preventing long-term damage to eyes, blood vessels, nerves, and other organs. Doctors often start with topical treatments and short courses of anti-inflammatory medicines for mouth or genital ulcers, skin lesions, and joint pain, and may add colchicine to reduce flare frequency. If symptoms are more severe—such as eye inflammation, blood clots, bowel involvement, or nervous system symptoms—immunosuppressive drugs like azathioprine, cyclosporine, methotrexate, or biologics (such as anti–TNF medicines) are used to protect organs and control disease activity. Treatment plans often combine several approaches, and a doctor may adjust your dose to balance benefits and side effects. Regular follow-up with rheumatology, ophthalmology, and other specialists helps track response, tailor therapy, and manage flares early.
Non-drug treatment
Behcet's disease can affect daily comfort, vision, and mobility, so non-drug care focuses on calming flares and protecting sensitive areas. Alongside medicines, non-drug therapies often steady symptoms between flares and help you stay active. Regular routines for skin, mouth, eyes, and joints can lower irritation and reduce setbacks. Noticing early symptoms of Behcet's disease—like a tingling sore or light sensitivity—lets you act quickly with soothing care.
Rinse with alcohol‑free mouthwash or saltwater to calm ulcers. A soft toothbrush and gentle flossing protect tender gums. Avoid spicy, acidic, or rough foods during flares.
Wear sunglasses outdoors to reduce light sensitivity. Seek urgent eye care for pain, redness, or vision changes. Keep follow‑up visits even when eyes feel normal.
Use bland, fragrance‑free cleansers and moisturizers to protect the skin barrier. Avoid tight clothing or friction over sensitive spots. Warm compresses can ease tender nodules.
Keep the area clean and dry, using gentle, unscented products. Loose, breathable underwear reduces rubbing and irritation. Barrier ointments can protect healing skin.
Your genes may have an impact on how drugs work for you
Some genes involved in immune signaling can change how strongly your body reacts to medicines for Behçet’s disease, affecting both benefit and side effects. Because of this variability, doctors may adjust drug choice or dose and sometimes use pharmacogenetic testing.
Pharmacological treatments
Treatment for Behcet’s disease focuses on easing flares quickly, protecting organs (especially the eyes and blood vessels), and keeping day-to-day symptoms under control. Plans are tailored to your mix of mouth sores, skin changes, joint pain, eye inflammation, blood vessel problems, or nerve involvement, and they may change over time. Not everyone responds to the same medication in the same way. Even when early symptoms of Behcet’s disease come and go, staying on a plan that prevents flares can help protect long-term health.
Ibuprofen or naproxen can ease pain and swelling during flares. Drugs that target symptoms directly are called symptomatic treatments.
Steroid mouth rinses or pastes (like dexamethasone rinse or triamcinolone paste) calm painful mouth ulcers. Steroid skin creams or eye drops may also reduce local inflammation.
Colchicine can reduce mouth sores, skin bumps, and aching joints. It is often used for frequent, milder symptoms.
Prednisone or methylprednisolone can quickly tamp down moderate to severe flares. Doctors may use short courses, then taper to limit side effects.
Genetic influences
Genes appear to set the stage for how the immune system reacts in Behcet's disease. The strongest known link is with a tissue-typing gene called HLA‑B51; carrying it raises risk, but most carriers never develop the condition. Family history is one of the strongest clues to a genetic influence. Even so, Behcet's disease does not follow a simple inheritance pattern, and many people are the only one in their family affected. Researchers think several genes work together like dimmer switches for immune activity, and environmental triggers—such as certain infections—may tip the balance. Because of this complexity, there isn’t a single genetic test that can diagnose Behcet's disease, and results like HLA‑B51 are used only as supporting information when clinicians weigh symptoms and exam findings. Researchers continue to study genetic risk factors for Behcet's disease across different populations.
Is Behcet's disease genetic?
Genetics play a meaningful role in Behcet’s disease, but they aren’t the whole story. Variants like HLA-B51 raise risk, especially in certain populations, yet many carriers never develop symptoms. Environment, infections, and immune triggers interact with these genetic factors.
Pharmacogenetics—how genetics influence drug effects
People with Behcet's disease often cycle through different medicines for mouth ulcers, eye flares, and joint pain, and genes can influence which drugs work best or cause side effects. Alongside medical history and lab results, genetic testing for TPMT—and in some groups NUDT15—can guide azathioprine dosing and help prevent dangerous low blood counts. For colchicine, differences in drug‑processing genes and transport proteins may change how much medicine stays in the body, but routine pharmacogenetic testing isn’t recommended; doctors instead adjust the dose and avoid strong interacting drugs, especially with kidney or liver problems. When cyclosporine is used for eye disease, inherited differences in liver enzyme and drug‑transport genes can affect blood levels, so clinicians rely on blood‑level monitoring and may consider genetics in select situations. Responses to biologic medicines like infliximab or adalimumab vary; early research links certain immune‑system gene patterns to a higher chance of forming anti‑drug antibodies, but this is not yet used routinely to choose a drug in Behcet's disease. An HLA‑B51 gene pattern is strongly linked to the risk of Behcet's disease, yet it does not currently steer day‑to‑day treatment choices. Overall, pharmacogenetic testing for Behcet's disease is most useful today when considering azathioprine, and it complements close follow‑up, side‑effect tracking, and dose adjustments over time.
Interactions with other conditions
People with Behcet’s disease may also live with conditions that affect the gut, blood vessels, or eyes, and the mix can change how flares feel and how treatments are chosen. Doctors call it a “comorbidity” when two conditions occur together, and Behcet’s sometimes overlaps with inflammatory bowel disease; mouth sores, abdominal pain, and bleeding can look similar, so teams may use scopes or imaging to tell them apart. Because early symptoms of Behcet’s disease, like mouth ulcers and fatigue, can resemble IBD flares or viral infections, having another illness at the same time can delay a clear diagnosis. Blood-clotting problems are another link: Behcet’s raises the chance of vein clots, and if someone also has an inherited clotting tendency such as factor V Leiden, the risk of deep vein thrombosis or a lung clot can be higher. Long-lasting inflammation from Behcet’s can strain the heart and arteries, so high blood pressure, diabetes, or high cholesterol may add to vascular complications; keeping these in range helps lower overall risk. Treatments matter, too—biologic medicines used for Behcet’s can interact with infections, and conditions like untreated tuberculosis or hepatitis B may reactivate, so screening and vaccines are important before and during therapy. These interactions vary widely, so care is often individualized to balance control of Behcet’s disease with the safe management of any other health issues.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described clusters of mouth sores, eye inflammation, and skin changes that came and went, sometimes alongside painful swelling in the joints or tender spots on the legs. In some families, relatives across generations shared similar bouts. A merchant might have paused a journey because of eye pain and blurry vision; a teacher might have missed work due to stubborn mouth ulcers that made eating difficult.
From early written records to modern studies, Behcet's disease has been linked to trade routes stretching from the Mediterranean across the Middle East and into East Asia. Doctors in these regions noticed patterns long before there was a unifying name. In the 1930s, a Turkish dermatologist, Hulusi Behçet, drew those threads together, describing a triad of symptoms—recurrent mouth sores, genital sores, and eye inflammation—that now define the classic picture. His reports helped connect what many had seen locally into one condition recognized worldwide.
Over time, descriptions became broader and more precise. Clinicians realized that Behcet's disease can also involve the skin, blood vessels, brain, and gut. This helped explain why some people had headaches or balance changes, while others had vein clots or abdominal pain during flares. As medical science evolved, different regions refined criteria to guide diagnosis, balancing the common features with the condition’s wide variability.
Advances in genetics added important context without replacing clinical observation. Researchers found certain immune-related markers, such as HLA-B51, appear more often in people with Behcet's disease, especially along the historic “Silk Road.” These markers do not cause the condition on their own, but they help explain why it clusters in some populations. At the same time, improved imaging and eye care reduced the risk of vision loss by catching inflammation earlier and treating it more effectively.
In recent decades, knowledge has built on a long tradition of observation. Large international studies have tracked how Behcet's disease behaves over time, which symptoms tend to appear first, and which treatments calm the immune system with fewer side effects. This work has led to steroid-sparing medicines and targeted therapies that were not available to earlier generations.
Looking back helps explain why Behcet's disease is diagnosed through a combination of symptoms, exam findings, and ruling out look-alike conditions, rather than a single lab test. The journey from scattered reports to today’s clearer framework reflects both the condition’s complexity and steady progress in care. While definitions have evolved, the goal remains the same: recognize Behcet's disease early, protect vision and vital organs, and help people live well between and during flares.